Disclosure Of Fair Value Measurement [Text Block]

Generix Group S.A. - Filing #2815373

Concept	As at 2022-03-31	As at 2022-03-31	As at 2022-03-31	As at 2022-03-31	As at 2022-03-31	As at 2022-03-31	As at 2022-03-31	As at 2022-03-31	As at 2021-03-31	As at 2021-03-31	As at 2021-03-31	As at 2021-03-31	As at 2021-03-31	As at 2021-03-31	As at 2021-03-31	As at 2021-03-31	As at 2020-03-31	As at 2020-03-31	As at 2020-03-31	As at 2020-03-31	As at 2020-03-31	As at 2020-03-31	As at 2020-03-31	As at 2020-03-31
Disclosure of fair value measurement [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets	—	—	120 068 EUR	—	—	—	—	—	115 459 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity	46 159 EUR	1 501 EUR	47 202 EUR	1 044 EUR	25 189 EUR	391,000 EUR	7 760 EUR	11 319 EUR	44 765 EUR	1 264 EUR	43 500 EUR	901,000 EUR	25 189 EUR	167,000 EUR	6 260 EUR	11 319 EUR	1 024 EUR	39 013 EUR	40 037 EUR	273,000 EUR	11 186 EUR	43,000 EUR	25 322 EUR	2 189 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]